who we are
our companies
stories
investors

Select Page

← Press Coverage

La Stampa

Genenta, Commissione UE concede Orphan Drug Designation a Temferon

29 June 2023

Genenta, Commissione UE concede Orphan Drug Designation a Temferon

Apri immagine a schermo intero ↗

CONTACT
NEWSROOM

© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963